Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis.
Saved in:
| Title: | Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. |
|---|---|
| Authors: | Hart A; St Mark's Hospital & Imperial College London, London, UK., Navabi S; United Medical Doctors, Long Beach, California, USA., D'Haens G; Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Matsuoka K; Toho University Sakura Medical Center, Sakura, Japan., Martín-Arranz MD; Department of Gastroenterology of La Paz University Hospital, School of Medicine, Universidad Autónoma de Madrid, Hospital La Paz Institute for Health Research, La Paz Hospital, Madrid, Spain., Atreya R; First Department of Medicine, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany., Samaan KH; Eli Lilly and Company, Indianapolis, Indiana, USA., Dhesi E; Eli Lilly and Company, Basingstoke, UK., Redondo I; Eli Lilly and Company, Indianapolis, Indiana, USA., Zhu B; Eli Lilly and Company, Indianapolis, Indiana, USA., Paulissen J; Syneos Health, Morrisville, North Carolina, USA., Zaremba-Pechmann L; HaaPACS GmbH, Schriesheim, Germany., Baygani S; Eli Lilly and Company, Indianapolis, Indiana, USA., Limdi J; Department of Gastroenterology, Northern Care Alliance NHS Trust, Manchester, UK., Laharie D; Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et Oncologie Digestive, Université de Bordeaux, Bordeaux, France., Danese S; Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Italy. |
| Source: | United European gastroenterology journal [United European Gastroenterol J] 2026 May; Vol. 14 (4), pp. e70214. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2050-6414 |
|---|---|
| DOI: | 10.1002/ueg2.70214 |
